China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China flag China · Delayed Price · Currency is CNY
25.20
-0.07 (-0.28%)
Aug 11, 2026, 1:40 PM CST

SHE:000999 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
31,80631,60327,61724,73918,07915,544
Revenue Growth
12.31%14.43%11.63%36.84%16.31%13.98%
Gross Profit
17,23917,03614,16413,0649,7258,984
Operating Income
4,3074,4304,1913,5432,7842,214
Net Income
3,2783,4213,3682,8532,4492,055
Earnings Per Share
1.972.062.021.721.471.24
EPS Growth
17.75%1.98%17.76%16.89%18.10%28.83%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Adjustment and Elimination
-894.19-1,681-779.42-329.31-269.6
Printing and Packaging
814.79883.42838.82833.38815.83
Medicines, Equipment Wholesale and Retail Industry Segment
3,3524,1733,231155.77115.1
Pharmaceutical
28,33024,24221,44917,42014,883
Total
31,60327,61724,73918,07915,544

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
9,6159,5576,6948,2273,1504,284
Total Debt
5,6946,4231,2852,998385.42232.18
Net Cash (Debt)
3,9203,1345,4095,2292,7644,052
Net Cash Growth
10.41%-42.05%3.45%89.15%-31.78%1.31%
Net Cash Per Share
2.361.893.243.141.662.45

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
-5,5134,4024,1923,0061,885
Capital Expenditures
--1,271-790.07-857.21-951.57-872.6
Free Cash Flow
-4,2423,6123,3352,0551,012
Free Cash Flow Growth
-17.43%8.33%62.28%103.03%-36.83%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
54.20%53.91%51.29%52.81%53.79%57.79%
Operating Margin
13.54%14.02%15.17%14.32%15.40%14.24%
Pretax Margin
15.01%15.39%16.63%15.18%16.39%15.72%
Profit Margin
10.30%10.82%12.20%11.53%13.54%13.22%
FCF Margin
-13.42%13.08%13.48%11.37%6.51%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
1.0401.0401.0150.8870.5920.505
Dividend Per Share Growth
-4.52%2.42%14.41%49.99%17.26%70.53%
Dividend Yield
4.14%3.75%3.12%3.31%2.39%2.84%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
12.8313.8516.9117.2318.8916.31
Forward PE
10.929.4016.0623.8421.6723.31
P/FCF Ratio
9.9311.1715.7714.7422.5233.12
PS Ratio
1.321.502.061.992.562.16